events
Mark your calendar for November 19-21 and meet us at Fi Europe 2024, Messe Frankfurt, Germany. We look forward to connecting with you at this exciting event!
Learn More >>
Services

Professional and Cost-Saving Solutions

Services
Online Inquiry

Our Products Cannot Be Used As Medicines Directly For Personal Use.

24 hour
Promise

Welcome! For price inquiries, please feel free to contact us through the form on the left side. We will get back to you as soon as possible.

Nanozymes for Live Cell and Organelle Imaging

Cytology is an important method for the diagnosis of clinical diseases. Currently, the most commonly used cytological tests are flow cytometry, cytological smear and nucleic acid detection. These traditional methods are characterized by high technical requirements, time-consuming or costly. However, chromogenic reactions driven by nanozymes can be used for qualitative and quantitative analysis of cytological features.

Nanozymes methods exhibit a broader promise for imaging of living cells and organelles, as enzyme assays are faster, more cost-effective, and easier to operate. Creative Enzymes provides a variety of nanozymes for the imaging of living cell and organelle types to improve healthcare using technology.

Imaging Type Observation Subject Nanozymes Visualization Method
Live cell Circulating tumor cells Fe3O4 Colorimetric method
Live cell Breast cancer cell SiO2 / Au Colorimetric method
Live cell Cervical cancer cells GO / Au Colorimetric detection
Live cell Melanoma tumor cell Fe3O4 Colorimetric method
Live cell Squamous cancer Au / Ag Electrochemical
Organelle Mitochondria Pd Biorthogonal reactions

Imaging of Circulating Tumor Cells with Nanozymes

  • Circulating tumor cells (CTCS) are promising biomarkers for monitoring cancer metastasis and response to therapy.

Imaging of circulating tumor cells based on nanozymes. - Creative EnzymesFig. 1 Imaging of circulating tumor cells based on nanozymes.

  • To allow simple and rapid CTC detection, Creative Enzymes proposes a method based on Fe3O4 nanozymes, to achieve rapid separation of CTCS as well as nanozyme activity.
  • The nanozyme can catalyze the oxidation of the colorimetric substrate TMB into blue product and realize visualization of CTCS. In addition, the visualized CTCS can be further quantified by UV-VIS measurements.

Imaging of Breast Cancer Cells with Nanozymes

  • Breast cancer is the most common malignancy and also the second leading cause of cancer mortality in women globally.
  • We develop an efficient method by detection of HER2+ breast cancer cells using an amplified signal scheme.

Imaging of breast cancer cells based on nanozymes. - Creative EnzymesFig. 2 Imaging of breast cancer cells based on nanozymes.

  • The utilization of MSNs as an excellent enzyme immobilization support and gold nanoclusters as an effective peroxidase mimic imparts high sensitivity to this detection platform.

Imaging of Mitochondria in Living Cells with Nanozymes

  • In addition to detecting CTCs, it is reported that researchers also employed the catalytic activity of nanozymes to design real-time detection probes for organelle imaging in living cells.
  • We construct a versatile light-controlled biorthogonal catalyst based on palladium nanozymes, which can effectively realize the specific imaging of mitochondria in living cells. Its catalytic activity can be regulated by light-induced structural changes, mimicking the allosteric regulation mechanism of biological enzymes.

Creative Enzymes provides customized nano-zymes for imaging living cells and organelles. We are pleased to share our cutting-edge technology and extensive expertise to facilitate our clients' research and project development. If you are interested in our services or have some questions, please feel free to contact us or make an online inquiry.

Our Products Cannot Be Used As Medicines Directly For Personal Use.